1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Clinical Trials Patent Approvals
Ask MarketMind AI
417.15 -0.35 (-0.08%)
1.4M
NSE+BSE Volume

NSE 27 Aug, 2026 1:36 PM (IST)

Watchlist

Portfolio

Alert

Regulatory Approval
Biocon's arm gets Japan MHLW nod for pegfilgrastim injection, targeting a $210.3 million market See details

Biocon RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Biocon technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis